PSMA-IN-3 (compound 17) is a novel, high-affinity inhibitor of Prostate-Specific Membrane Antigen (PSMA) with an IC50 of 13 nM, showing potential for development as an 18F-labeled radioligand for PET imaging of PSMA in prostate cancer [1].
Molecular Weight:
923.89
Formula:
C43H50FN7O15
Target:
Others
* VAT and and shipping costs not included. Errors and price changes excepted
